'Well resourced...very efficient...and extremely responsive', the majority of Milbank's nascent London private equity practice joined the firm from Dickson Minto WS in March 2023. The practice is jointly chaired by former Dickson Minto partner Jordan Simpson and former Kirkland partner Andrej Wolf, who also co-heads the London office. The pair steer the team across multi-jurisdictional acquisitions, sales, investment deals, and restructurings. Simpson is a highly experienced transactional lawyer whose recent engagements include cross-border sell-side mandates, while Wolf's capabilities span acquisitions and follow-on investments, acting for both PE houses and their portfolio companies. Other key figures include James McClymont, who boasts particular expertise in shareholder arrangements, and Lara Watt, a 'highly knowledgeable and commercial' adviser with experience across buyouts, carve-outs, and bolt-on acquisitions.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

'The firm offers a well resourced, highly knowledgeable team to guide a deal from start to finish. The team is very experienced and, as a result, has excellent market awareness. The partners manage their teams very efficiently and tasks are allocated appropriately to different levels of seniority, thus providing an effective, safe and cost efficient service. All individuals are very easy to deal with and extremely responsive.'
'Lara Watt is highly knowledgeable and commercial in her approach.'

Key clients

A&M Capital Europe
Cerberus European Investments
Charterhouse Capital Partners
Compass Partners
Intermediate Capital Group
Investindustrial
PAI Partners
Park Square Capital
Stirling Square Capital Partners
Summit Partners
Sun European Partners
The Carlyle Group
Värde Partners
Vitruvian Partners

Work highlights

Advised Vitruvian Partners on its co-investment, alongside EQT, in CFC Underwriting.
Advised Charterhouse on the sale of SLR Consulting, implemented by private scheme of arrangement.
Represented Universal Partners on the sale of Dentex Healthcare Group to Portman Healthcare, including in respect of the associated Phase 1 CMA clearance.